| Literature DB >> 34203966 |
Olga Tsivileva1, Alexander Pozdnyakov2, Anastasiya Ivanova2.
Abstract
Nanoparticle-reinforced polymer-based materials effectively combine the functional properties of polymers and unique characteristic features of NPs. Biopolymers have attained great attention, with perspective multifunctional and high-performance nanocomposites exhibiting a low environmental impact with unique properties, being abundantly available, renewable, and eco-friendly. Nanocomposites of biopolymers are termed green biocomposites. Different biocomposites are reported with numerous inorganic nanofillers, which include selenium. Selenium is a micronutrient that can potentially be used in the prevention and treatment of diseases and has been extensively studied for its biological activity. SeNPs have attracted increasing attention due to their high bioavailability, low toxicity, and novel therapeutic properties. One of the best routes to take advantage of SeNPs' properties is by mixing these NPs with polymers to obtain nanocomposites with functionalities associated with the NPs together with the main characteristics of the polymer matrix. These nanocomposite materials have markedly improved properties achieved at low SeNP concentrations. Composites based on polysaccharides, including fungal beta-glucans, are bioactive, biocompatible, biodegradable, and have exhibited an innovative potential. Mushrooms meet certain obvious requirements for the green entity applied to the SeNP manufacturing. Fungal-matrixed selenium nanoparticles are a new promising biocomposite material. This review aims to give a summary of what is known by now about the mycosynthesized selenium polymeric nanocomposites with the impact on fungal-assisted manufactured ones, the mechanisms of the involved processes at the chemical reaction level, and problems and challenges posed in this area.Entities:
Keywords: fungi; green synthesis; mechanism; mushrooms; polymer nanocomposites; selenium nanoparticles; selenium-containing biocomposites
Mesh:
Substances:
Year: 2021 PMID: 34203966 PMCID: PMC8232642 DOI: 10.3390/molecules26123657
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Scheme of DAPS-25 biotransformation.
Figure 2Schematic structure of fragment of arabinogalactan.
Figure 3Schematic structure of fragments of β-(1,3)– and β-(1,3),(1,4)–glucans.
Figure 4Reversible transitions among NADH and NAD+.
Figure 5Structure of the compound DAPS-25.
Figure 6Scheme of DAPS-25 interaction with thiols.
Figure 7Scheme of sodium selenite interaction with reduced glutathione.